PRVA Privia Health Group Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: PRVA

Price (delayed)

$21.4

Market cap

$2.7B

P/E Ratio

118.89

Dividend/share

N/A

EPS

$0.18

Enterprise value

$2.29B

?
Relative Growth: Rel. Growth: 69
Relative Strength: Rel. Strength: 27
Relative Valuation: Rel. Valuation: 38
Relative Profitability: Rel. Profitability: 28

Privia Health™ is a technology-driven, national physician enablement company that collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for ...

Highlights
The revenue rose by 25% YoY and by 6% QoQ
The gross profit has grown by 23% YoY and by 7% from the previous quarter
Privia Health Group's debt has soared by 66% YoY but it has decreased by 5% from the previous quarter
Privia Health Group's net income has increased by 39% YoY but it has decreased by 5% from the previous quarter
The quick ratio is down by 15% YoY
Sector: Healthcare
Industry: Health Information Services
Website: http://www.priviahealth.com

Key stats

What are the main financial stats of PRVA

PRVA stock price

How has the Privia Health Group stock price performed over time
Intraday
3.58%
1 week
-0.88%
1 month
-11.72%
1 year
-7%
YTD
-9.74%
QTD
4.04%

Financial performance

How have Privia Health Group's revenue and profit performed over time
Revenue
$2.25B
Gross profit
$223.98M
Operating income
$36.44M
Net income
$21.76M
Gross margin
10%
Net margin
1%
PRVA's operating income has surged by 70% year-on-year and by 6% since the previous quarter
Privia Health Group's net income has increased by 39% YoY but it has decreased by 5% from the previous quarter
The operating margin rose by 33% YoY
The revenue rose by 25% YoY and by 6% QoQ

Price vs fundamentals

How does PRVA's price correlate with its fundamentals

Growth

What is Privia Health Group's growth rate over time

Valuation

What is Privia Health Group stock price valuation
PRVA P/E details
P/E
118.89
P/B
3.51
P/S
1.18
EV/EBIT
57.92
EV/EBITDA
45.04
EV/Sales
1.02
Privia Health Group's EPS has increased by 38% YoY but it has decreased by 5% QoQ
PRVA's P/E is 23% below its last 4 quarters average of 149.2
PRVA's price to book (P/B) is 37% less than its 5-year quarterly average of 5.4 and 13% less than its last 4 quarters average of 3.9
The company's equity rose by 14% YoY and by 2.1% QoQ
The stock's price to sales (P/S) is 43% less than its 5-year quarterly average of 2.0 and 19% less than its last 4 quarters average of 1.4
The revenue rose by 25% YoY and by 6% QoQ

Efficiency

How efficient is Privia Health Group business performance
PRVA's ROE is up by 20% YoY but it is down by 9% QoQ
Privia Health Group's return on sales has increased by 20% YoY and by 6% QoQ
The return on assets has increased by 14% year-on-year but it has declined by 11% since the previous quarter

Dividends

What is PRVA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PRVA.

Financial health

How did Privia Health Group financials performed over time
Privia Health Group's total assets is 132% higher than its total liabilities
The total liabilities rose by 29% YoY and by 6% QoQ
Privia Health Group's total assets has increased by 20% YoY and by 3.5% QoQ
Privia Health Group's debt is 99% less than its equity
Privia Health Group's debt has soared by 66% YoY but it has decreased by 5% from the previous quarter
The company's equity rose by 14% YoY and by 2.1% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.